Elsevier

Phytomedicine

Volume 7, Issue 5, October 2000, Pages 351-364
Phytomedicine

Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human

https://doi.org/10.1016/S0944-7113(00)80054-9Get rights and content

Summary

Validated analytical methods (HPLC, CE and GC-MS) for determining the amount of andrographolide (AND) in the blood plasma of rats and human volunteers following the oral administration of Andrographis paniculata extract (APE) and Andrographis paniculata fixed combination Kan Jang tablets were developed and used for the pharmacokinetic study. Andrographolide was quickly and almost completely absorbed into the blood following the oral administration of APE at a dose of 20 mg/kg body wt. in rats. Its bio-availability, however, decreased four-fold when a 10-times-higher dose was used. Since a large part (55%) of AND is bound to plasma proteins and only a limited amount can enter the cells, the pharmacokinetics of AND are described well by a one-compartment model. Renal excretion is not the main route for eliminating AND. It is most likely intensely and dose dependency metabolized. Following the oral administration of four Kan Jang tablets (a single therapeutic dose, equal to 20 mg of AND) to humans, maximum plasma levels of approximately 393 ng/ml (approx. 1.12 μM) were reached after 1.5–2 hours, as quantified using a UV diode-array detection method. Half-life and mean residence times were 6.6 and 10.0 hours, respectively. AND pharmacokinetics in humans are explained well by an open two-compartment model. The calculated steady state plasma concentration of AND for multiple doses of Kan Jang (after the normal therapeutic dose regimen, 3 × 4 tablets/day, about 1 mg AND/kg body wt./day) was approximately 660 ng/ml (approx. 1.9 μM), enough to reveal any anti-PAF effect, particularly after drug uptake when the concentration of AND in blood is about 1342 ng/ml (approx. 3.8 μM, while for anti-PAF effect EC50 — 5 μM).

References (39)

  • E. Amroyan et al.

    Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation

    Phytomedicine

    (1999)
  • C.Y. Zhang et al.

    Mechanisms of cardiovascular activity of Andrographis paniculata in the anaesthetized rat

    J. Ethnopharmacol.

    (1997)
  • M. Borhanuddin

    Hypoglycemic effects of Andrographis paniculata Nees on non-diabetic rabbits

    Bangladesh Med. Res. Counc. Bull.

    (1994)
  • R. Burgos et al.
  • D.D. Caceras et al.

    Prevention of common colds with Andrographis Paniculata dried extract: A Pilot double blind trial

    Phytomedicine

    (1997)
  • M.P. Cava et al.

    Andrographolide. Further transformations and stereochemical evidence of the structure of isoandrographolide

    Tetrahedron

    (1965)
  • D. Chakravati et al.

    Andrographolide. Part 1

    J. Chem. Soc.

    (1952)
  • H.M. Chang et al.

    Pharmacology and Applications of Chinese Materia Medica

    (1987)
  • R.S. Chang et al.

    Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus

    Proc. Soc. Exp. Biol. Med.

    (1991)
  • W-F. Chiou et al.

    Andrographolide suppresses the LPS-inducible expression of nitric oxide synthase in macrophages

    British J. Pharmacol.

    (1998)
  • Dymock, W., Warden, C.J.H., Hooper, D.: Pharmacographica Indica A history of the Principal Drugs of Vegetable Origin...
  • EC-Guideline 111/3445/91-EN: Causality classification in pharmaco-vigilance in the European...
  • E.R. Garrett

    Pharmacokinetic and clearance related to renal processes

    Int. J. Clin. Pharmacol.

    (1978)
  • E. Gladtke et al.

    Pharmacokinetic, Berlin, N.-Y, S.-Y.

    (1977)
  • Z.L. Guo

    The effect of Andrographis paniculata nees (APN) in alleviating the myocardial ischemic reperfusion injury

    J. Tongji Med. Univ.

    (1994)
  • Z.L. Guo et al.

    An experimental study of the mechanism of Andrographis paniculata Nees (APN) in alleviating the Ca(2+)-overloading in the process of myocardial ischemic reperfusion

    J. Tongji Med. Univ.

    (1995)
  • P.P. Gupta et al.

    Antiallergic activity of andrographiolides isolated from Andrographis paniculata (Burm.F.) Wall

    Pharmaceutical Biology

    (1998)
  • J. Hancke et al.

    A Double-blind study with a new monodrug Kan Jang: Decrease of symptoms and improvements in the recovery from common colds

    Phytotherapy Res.

    (1995)
  • Cited by (192)

    • Pharmacokinetics

      2023, Pharmacognosy: Fundamentals, Applications, and Strategies, Second Edition
    View all citing articles on Scopus
    *

    Address A. Panossian, Guelbenkian Research & Drug Quality Control Laboratory of ADMTA, 49/4 Komitas str., Yerevan-51, 375051 Armenia. Fax: 003742-280733

    View full text